Medtronic announces cash dividend for third quarter of fiscal year 2026

Medtronic (NYSE: MDT) announced a $0.71 per share cash dividend for Q3 of fiscal 2026.

Rhea-AI Summary

Medtronic (NYSE: MDT) announced a $0.71 per share cash dividend for Q3 of fiscal 2026. The board approved the dividend on December 4, 2025, payable on January 16, 2026 to shareholders of record at the close of business on December 26, 2025.

This declaration is consistent with the company's May 2025 dividend increase and continues Medtronic's track record as a S&P 500 Dividend Aristocrat, having raised its annual dividend for 48 consecutive years.

Positive

• Quarterly dividend of $0.71 per share
• Dividend payable on January 16, 2026
• Record date set at December 26, 2025
• 48 consecutive years of annual dividend increases

Negative

• None.

Argus Dec 5 session

-0.62% close to close Open Argus

Details

News Market Reaction – MDT

On Dec 5, the first trading day after this news, MDT closed 0.62% below the previous close.

Data tracked by StockTitan Argus for the Dec 5 session.

Market Context

This announcement confirmed a Q3 FY26 cash dividend of $0.71 per ordinary share, consistent with Med...

Analysis

This announcement confirmed a Q3 FY26 cash dividend of $0.71 per ordinary share, consistent with Medtronic’s May 2025 increase and its 48-year record of annual dividend growth as part of the S&P 500 Dividend Aristocrats index. In context of recent strong Q2 FY26 results and continued product and regulatory milestones, the dividend underscores a stable capital return framework. Investors may watch future dividend declarations and earnings updates for any change in payout level or guidance trends.

Key Figures

Quarterly dividend: $0.71 per ordinary share Dividend growth streak: 48 consecutive years Dividend pay date: January 16, 2026 +5 more

Quarterly dividend

$0.71 per ordinary share

Q3 fiscal 2026 dividend approved Dec 4, 2025

Dividend growth streak

48 consecutive years

Years of annual dividend increases as of Dec 2025

Dividend pay date

January 16, 2026

Payable date for Q3 FY26 dividend

Record date

December 26, 2025

Shareholders of record for Q3 FY26 dividend

Employees

95,000+ people

Global Medtronic workforce mentioned in company description

Countries served

150+ countries

Geographic reach of Medtronic’s operations

Health conditions

70 conditions

Number of health conditions treated by company technologies

Patients helped

Two people every second

Stated rate of lives impacted by Medtronic therapies

Historical Context

5 past events · Latest: Dec 04

5 events

1. Dec 04

   Dividend declaration

   24h Move

   -0.6%

   Board approved Q3 FY26 cash dividend of $0.71 per ordinary share.

2. Dec 03

   Regulatory clearance

   24h Move

   +0.0%

   FDA clearance of Hugo robotic-assisted system for urologic procedures.

3. Dec 02

   Product launch

   24h Move

   -1.3%

   U.S. launch of MiniMed 780G system integrated with Instinct sensor.

4. Nov 18

   Earnings results

   24h Move

   +4.7%

   Q2 FY26 revenue and EPS growth with raised full-year guidance.

5. Nov 05

   Earnings preview

   24h Move

   -0.4%

   Announcement of timing and access details for Q2 FY26 results.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

ordinary share, S&P 500 Dividend Aristocrats index, forward-looking statements

3 terms

ordinary share financial

"approved the company's cash dividend for the third quarter... of $0.71 per ordinary share."

An ordinary share is a unit of ownership in a company that gives the holder a stake in its profits and usually the right to vote on key decisions. Think of it like a slice of a pizza where each slice entitles you to a portion of what’s left after bills are paid; value can rise or fall with the business and may pay dividends, so it matters to investors for income, growth and control.

S&P 500 Dividend Aristocrats index financial

"Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend..."

A stock index composed of S&P 500 companies that have raised their dividends every year for a long, specified stretch, serving as a list of firms with steady income-growing records. For investors, it acts like a curated “reliable-payer” roster — useful for finding stocks that may offer consistent cash returns and lower volatility compared with the broader market, similar to choosing appliances from brands known for durability.

forward-looking statements regulatory

"Any forward-looking statements are subject to risks and uncertainties such as those described..."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GALWAY, Ireland, Dec. 4, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2025. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 48 consecutive years. The dividend is payable on January 16, 2026, to shareholders of record at the close of business on December 26, 2025.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Jane Di Leo
Public Relations
jane.e.dileo@medtronic.com

Ryan Weispfenning
Investor Relations
+1-763-505-4626

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-announces-cash-dividend-for-third-quarter-of-fiscal-year-2026-302633588.html

SOURCE Medtronic plc

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What dividend did Medtronic (MDT) declare for Q3 fiscal 2026?

Medtronic declared a $0.71 per share cash dividend for Q3 fiscal 2026.

When is the Medtronic (MDT) Q3 fiscal 2026 dividend payable?

The dividend is payable on January 16, 2026.

What is the record date to receive Medtronic's (MDT) January 2026 dividend?

Shareholders of record at the close of business on December 26, 2025 will receive the dividend.

Does Medtronic (MDT) still qualify as a Dividend Aristocrat in 2025?

Yes. Medtronic is listed as an S&P 500 Dividend Aristocrat with 48 consecutive years of raises.

Was the Q3 fiscal 2026 dividend consistent with prior guidance from Medtronic?

Yes. The $0.71 quarterly declaration is consistent with the dividend increase announced in May 2025.